Antibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: a single center study

Abstract Background Pulmonary exacerbations (PEx) are a major driver of morbidity and mortality in cystic fibrosis and reducing their frequency by extending the time between them is an important therapeutic goal. Although treatment decisions for exacerbations are often made based on dynamic changes...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Julia C. Espel, Hannah L. Palac, Joanne F. Cullina, Alexandria P. Clarke, Susanna A. McColley, Michelle H. Prickett, Manu Jain
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMC 2017-11-01
Reeks:BMC Pulmonary Medicine
Onderwerpen:
Antibiotics
Bronchiectasis
Cystic fibrosis
Exacerbation
Outcomes Pseudomonas aeruginosa
Online toegang:http://link.springer.com/article/10.1186/s12890-017-0503-6
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items